speb/financial-data huggingface dataset:
Financial ratios for PCRX.V — annual report dated 2025-12-31
Total revenue: 15251464.963503648
Gross profit: 6057133.576642335
Operating income: -903424.8175182481
Net income: -1037997.810218978
Capital expenditures: 1589490.510948905
Operating cash flow: 1464501.4598540145
Depreciation & amortization: 686274.4525547444
Net tangible assets: 15855481.751824817
Owner earnings: -1941213.8686131386
Return on net tangible assets (%): -12.243171787509535
Buffett classification: The Gruesome
Stock price: 0.3357664233576642
Shares outstanding: 196630859
Book value: 38153230.656934306
P/B ratio: 1.7304442929572923
Market cap (USD): 66022040.24817518
Debt to equity: 0.08696174545952103
Current ratio: 5.144654976815773
Quick ratio: 4.679033538166492
Interest coverage ratio: -12.417026997200958
COGS to revenue (%): 60.28490645890808
SG&A to revenue (%): 41.13889358576395
Free cash flow (dilution-adjusted): -421093.4306569343
Buyback yield (%): 0
Retained earnings: -2293351.8248175182
Inventory turnover: 4.656385054745518
Receivables turnover: 17.155401472139776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0710866041078564
FCF margin (%): -2.7610031670046107
Revenue growth (%): 276.357524853867
Rule of 40 score: 273.5965216868624
Financial ratios for PCRX.V — quarterly report dated 2025-12-31
Total revenue: 5612832.116788321
Gross profit: 2165584.6715328465
Operating income: -464497.08029197075
Net income: -622177.3722627737
Capital expenditures: 1539674.4525547444
Operating cash flow: 1104671.5328467153
Depreciation & amortization: 249464.9635036496
Net tangible assets: 15855481.751824817
Owner earnings: -1912386.8613138685
Return on net tangible assets (%): -12.06136080408765
Buffett classification: The Gruesome
Stock price: 0.3357664233576642
Shares outstanding: 196630859
Book value: 38153230.656934306
P/B ratio: 1.7304442929572923
Market cap (USD): 66022040.24817518
Debt to equity: 0.08696174545952103
Current ratio: 5.144654976815773
Quick ratio: 4.679033538166492
Interest coverage ratio: -12.024280558547323
COGS to revenue (%): 61.41725555882115
SG&A to revenue (%): 42.413824942324545
Free cash flow (dilution-adjusted): -581422.6277372262
Buyback yield (%): 0
Retained earnings: -2293351.8248175182
Inventory turnover: 1.7458269458326388
Receivables turnover: 6.313517330279034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0648519522439182
FCF margin (%): -10.358810234109013
Revenue growth (%): 62.461804795113416
Rule of 40 score: 52.1029945610044
Financial ratios for PLSR.L — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -13846.875
Operating income: -2009632.2916666667
Net income: -3904348.9583333335
Capital expenditures: 329550
Operating cash flow: -2381883.3333333335
Depreciation & amortization: 13846.875
Net tangible assets: -1158077.0833333335
Owner earnings: -4220052.083333334
Buffett classification: The Gruesome
Stock price: 0.003375
Shares outstanding: 214066747
Book value: -1158077.083333333
Market cap (USD): 722475.271125
Debt to equity: 0
Current ratio: 4.8071881906897165
Quick ratio: 4.8071881906897165
Free cash flow (dilution-adjusted): -2902571.875
Buyback yield (%): 0
Retained earnings: -28023053.125
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.097931704695064
Rule of 40 score: 0
Financial ratios for PLSR.L — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -14343.478260869564
Operating income: -6262677.173913043
Net income: -3663455.4347826084
Capital expenditures: 263377.17391304346
Operating cash flow: -4041263.0434782607
Depreciation & amortization: 14343.478260869564
Net tangible assets: -2618043.4782608696
Owner earnings: -3912489.1304347822
Buffett classification: The Gruesome
Stock price: 0.0035064935064935067
Shares outstanding: 214066747
Book value: -2618043.478260869
Market cap (USD): 750623.6583116883
Debt to equity: 0
Current ratio: 0.6802984137758082
Quick ratio: 0.6802984137758082
Free cash flow (dilution-adjusted): -4431216.304347825
Buyback yield (%): 0
Retained earnings: -32904902.173913043
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2074.8842217468637
Rule of 40 score: 0
Financial ratios for PLSR.L — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -15914.117647058823
Operating income: -1677050.5882352942
Net income: -1643158.8235294118
Capital expenditures: 0
Operating cash flow: -4167367.0588235296
Depreciation & amortization: 15914.117647058823
Net tangible assets: -4379681.176470588
Owner earnings: -1627244.705882353
Buffett classification: The Gruesome
Stock price: 0.0036986301369863017
Shares outstanding: 214066747
Book value: -4379681.176470588
Market cap (USD): 791753.721780822
Debt to equity: -0.6989944742150181
Current ratio: 0.1362029378731992
Quick ratio: 0.1362029378731992
Interest coverage ratio: -13.9525776424873
Free cash flow (dilution-adjusted): -4264507.05882353
Buyback yield (%): 0
Retained earnings: -37257891.76470588
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLSR.L — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -15978.823529411766
Operating income: -2106476.470588235
Net income: -1330161.1764705882
Capital expenditures: 0
Operating cash flow: -1616067.0588235294
Depreciation & amortization: 15978.823529411766
Net tangible assets: -223560
Owner earnings: -1314182.3529411764
Buffett classification: The Gruesome
Stock price: 0.003243243243243243
Shares outstanding: 214066747
Book value: -223560
Market cap (USD): 694270.5308108107
Debt to equity: 0
Current ratio: 0.5049928345440483
Quick ratio: 0.5049928345440483
Interest coverage ratio: -19.98710692876997
Free cash flow (dilution-adjusted): -1714274.1176470588
Buyback yield (%): 0
Retained earnings: -38588052.941176474
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLSR.L — annual report dated 2025-09-30
Total revenue: 0
Gross profit: -63056.470588235294
Operating income: -12857111.764705883
Net income: -11348104.705882354
Capital expenditures: 657264.705882353
Operating cash flow: -12847634.11764706
Depreciation & amortization: 63056.470588235294
Net tangible assets: -223560
Owner earnings: -11942312.941176472
Buffett classification: The Gruesome
Stock price: 0.003243243243243243
Shares outstanding: 214066747
Book value: -223560
Market cap (USD): 694270.5308108107
Debt to equity: 0
Current ratio: 0.5049928345440483
Quick ratio: 0.5049928345440483
Interest coverage ratio: -56.99371577574968
Free cash flow (dilution-adjusted): -14053120.000000002
Buyback yield (%): 0
Retained earnings: -38588052.941176474
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLSR.L — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -15885.882352941177
Operating income: -4526436.470588235
Net income: -8373971.764705882
Capital expenditures: 4647.058823529412
Operating cash flow: -3581236.470588235
Depreciation & amortization: 15885.882352941177
Net tangible assets: 3127329.411764706
Owner earnings: -8362732.941176471
Return on net tangible assets (%): -267.4081249553274
Buffett classification: The Gruesome
Stock price: 0.006486486486486486
Shares outstanding: 214066747
Book value: 3127329.411764706
P/B ratio: 0.4440021752739147
Market cap (USD): 1388541.0616216215
Debt to equity: 0
Current ratio: 1.733398671111756
Quick ratio: 1.733398671111756
Free cash flow (dilution-adjusted): -4586054.117647059
Buyback yield (%): 0
Retained earnings: -46962024.705882356
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -144.7380775929848
Rule of 40 score: 0
Financial ratios for SCYR.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.0454545454545454
Shares outstanding: 799720793
Market cap (USD): 1635792531.1363635
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCYR.MC — annual report dated 2022-12-31
Total revenue: 5294646808.510638
Gross profit: 3522754255.319149
Operating income: 1301767021.2765958
Net income: 364874468.08510643
Capital expenditures: 607378723.4042554
Operating cash flow: 749904255.319149
Depreciation & amortization: 162986170.21276596
Net tangible assets: 353242553.1914894
Owner earnings: -79518085.10638297
Return on net tangible assets (%): -22.510902038259523
Capex to operating income (%): 46.65802048116268
Buffett classification: The Good
Stock price: 2.2872340425531914
P/E ratio: 5.013090205754237
Shares outstanding: 799720793
Book value: 1445120212.7659569
P/B ratio: 1.2657414975784247
Market cap (USD): 1829148622.287234
Debt to equity: 7.406873314669401
Current ratio: 1.2667179896529435
Quick ratio: 1.2354578301010892
Effective tax rate (%): 32.48466047026413
Interest coverage ratio: 2.1732067409384674
COGS to revenue (%): 33.46573656893113
SG&A to revenue (%): 31.735506436850713
Free cash flow (dilution-adjusted): 128384042.5531915
Buyback yield (%): 1.0322788790123782
Retained earnings: 117570212.76595746
Inventory turnover: 12.004172972972974
Receivables turnover: 2.5077497877443458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.32890504347948
FCF margin (%): 2.424789550585819
Rule of 40 score: 2.424789550585819
Financial ratios for SCYR.MC — annual report dated 2023-12-31
Total revenue: 5121586666.666667
Gross profit: 3604060000
Operating income: 1275203333.3333333
Net income: 389148888.8888889
Capital expenditures: 222560000
Operating cash flow: 941762222.2222222
Depreciation & amortization: 176085555.55555555
Net tangible assets: 777746666.6666666
Owner earnings: 342674444.4444444
Return on net tangible assets (%): 44.05990525335299
Capex to operating income (%): 17.45290293574097
Buffett classification: The Great
Stock price: 3.0888888888888886
P/E ratio: 6.347824039185229
Shares outstanding: 799720793
Book value: 1944467777.7777786
P/B ratio: 1.2703983578139912
Market cap (USD): 2470248671.711111
Debt to equity: 5.1495199200466715
Current ratio: 1.0880866691810975
Quick ratio: 1.0621372041876493
Effective tax rate (%): 91.63887078429117
Interest coverage ratio: 1.4276493132826718
COGS to revenue (%): 29.630010491540382
Free cash flow (dilution-adjusted): 693678888.8888888
Buyback yield (%): 4.172814262358752
Retained earnings: 170246666.66666666
Inventory turnover: 8.316277880276932
Receivables turnover: 2.5921088888314046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.452632942210665
FCF margin (%): 13.544218501731667
Revenue growth (%): -3.2685870862206263
Rule of 40 score: 10.27563141551104
Financial ratios for SCYR.MC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3555555555555556
Shares outstanding: 799720793
Market cap (USD): 2683507549.8444443
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCYR.MC — quarterly report dated 2024-12-31
Total revenue: 1363697916.6666667
Operating income: 325375000
Net income: 124610416.66666667
Capital expenditures: 0
Depreciation & amortization: 43958333.333333336
Owner earnings: 168568750
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.0833333333333335
P/E ratio: 4.947029799709093
Shares outstanding: 799720793
Market cap (USD): 2465805778.416667
Effective tax rate (%): 33.133597536094975
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 118096875
Inventory turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCYR.MC — annual report dated 2024-12-31
Total revenue: 4761462500
Gross profit: 3249793750
Operating income: 1234609375
Net income: 268471875
Capital expenditures: 259848958.33333334
Operating cash flow: 1347793750
Depreciation & amortization: 169623958.33333334
Net tangible assets: 955323958.3333334
Owner earnings: 178246875.00000003
Return on net tangible assets (%): 18.658264921040093
Capex to operating income (%): 21.047058575375985
Buffett classification: The Great
Stock price: 3.0833333333333335
P/E ratio: 9.18459625767752
Shares outstanding: 799720793
Book value: 2148587500.000002
P/B ratio: 1.1476403816072953
Market cap (USD): 2465805778.416667
Debt to equity: 5.014393176912734
Current ratio: 1.153697861682345
Quick ratio: 1.1262831828765874
Effective tax rate (%): 39.98630829163339
Interest coverage ratio: 1.5817383273857026
COGS to revenue (%): 31.747992344789022
Free cash flow (dilution-adjusted): 1001391666.6666667
Buyback yield (%): 0.3682873192807268
Retained earnings: 118096875
Inventory turnover: 10.94470338024345
Receivables turnover: 2.5173319058735673
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.025599279307544
FCF margin (%): 21.03117827068189
Revenue growth (%): -7.031496098865202
Rule of 40 score: 13.99968217181669
Financial ratios for SCYR.MC — quarterly report dated 2025-03-31
Total revenue: 1151116304.347826
Operating income: 287222826.0869565
Net income: 65142391.30434782
Capital expenditures: 0
Depreciation & amortization: 61169565.217391305
Net tangible assets: 991351086.9565217
Owner earnings: 126311956.52173913
Return on net tangible assets (%): 12.741394868443704
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.33695652173913
P/E ratio: 10.241539580976456
Shares outstanding: 799720793
Book value: 2268000000
P/B ratio: 1.1766461709751934
Market cap (USD): 2668633515.7717385
Debt to equity: 4.123439536845333
Current ratio: 1.0629758590187461
Quick ratio: 1.0358420561344948
Effective tax rate (%): 38.53167724797177
COGS to revenue (%): 0
Buyback yield (%): 0
Inventory turnover: 0
Receivables turnover: 0.2797070203087475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.282310527934109
Revenue growth (%): -15.588614583973348
Rule of 40 score: -15.588614583973348
Financial ratios for SCYR.MC — quarterly report dated 2025-06-30
Total revenue: 1385641176.4705882
Operating income: 314217647.0588235
Net income: 64677647.05882353
Capital expenditures: 0
Depreciation & amortization: 48916470.5882353
Net tangible assets: 964375294.117647
Owner earnings: 113594117.64705883
Return on net tangible assets (%): 11.779036474694378
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.9411764705882355
P/E ratio: 12.38782822615373
Shares outstanding: 799720793
Book value: 2414615294.117649
P/B ratio: 1.3053179858878983
Market cap (USD): 3151840772.411765
Debt to equity: 4.380579929186134
Current ratio: 1.1413971276616934
Quick ratio: 1.1224731589745631
Effective tax rate (%): 48.11627029067573
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 35902352.941176474
Inventory turnover: 0
Receivables turnover: 0.7480286205678893
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2867729851786356
Revenue growth (%): 20.37369041138151
Rule of 40 score: 20.37369041138151
Financial ratios for SCYR.MC — quarterly report dated 2025-09-30
Total revenue: 1382332941.1764705
Operating income: 313438823.5294118
Net income: 77810588.23529412
Capital expenditures: 0
Depreciation & amortization: 53709411.76470588
Net tangible assets: 987870588.2352941
Owner earnings: 131520000
Return on net tangible assets (%): 13.313484738415369
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.047058823529412
P/E ratio: 9.741472817034861
Shares outstanding: 799720793
Book value: 2511908235.294121
P/B ratio: 1.2884694775848857
Market cap (USD): 3236517091.670588
Debt to equity: 3.8654798180150785
Current ratio: 1.1108091905196693
Quick ratio: 1.0861936100092044
Effective tax rate (%): 42.33287703481528
COGS to revenue (%): 0
Buyback yield (%): 0
Inventory turnover: 0
Receivables turnover: 0.315917979515313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2708772688273484
Revenue growth (%): -0.2387512258075502
Rule of 40 score: -0.2387512258075502
Financial ratios for SCYR.MC — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 1123562352.9411764
Buffett classification: The Gruesome
Stock price: 4.4
P/E ratio: 16.94726614684313
Shares outstanding: 799720793
Book value: 2591431764.705883
P/B ratio: 1.3578484053194304
Market cap (USD): 3518771489.2000003
Debt to equity: 4.243611866617454
Current ratio: 1.1499163468318616
Quick ratio: 1.1253574731154452
Buyback yield (%): 0
Retained earnings: 100925882.35294119
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCYR.MC — annual report dated 2025-12-31
Total revenue: 5481810588.235294
Gross profit: 3691158823.529412
Operating income: 1342723529.4117649
Net income: 274870588.2352941
Capital expenditures: 284275294.11764705
Operating cash flow: 1598358823.5294118
Depreciation & amortization: 217035294.11764705
Net tangible assets: 1123562352.9411764
Owner earnings: 207630588.2352941
Return on net tangible assets (%): 18.479667611839652
Capex to operating income (%): 21.171543351309673
Buffett classification: The Great
Stock price: 4.4
P/E ratio: 12.801556950094165
Shares outstanding: 799720793
Book value: 2591431764.705883
P/B ratio: 1.3578484053194304
Market cap (USD): 3518771489.2000003
Debt to equity: 4.243611866617454
Current ratio: 1.1499163468318616
Quick ratio: 1.1253574731154452
Effective tax rate (%): 42.93683338991454
Interest coverage ratio: 1.6127215820374596
COGS to revenue (%): 32.6653344890986
Free cash flow (dilution-adjusted): 1298296470.5882354
Buyback yield (%): 0.00655308922451632
Retained earnings: 100925882.35294119
Inventory turnover: 12.282553260167848
Receivables turnover: 2.849693168988846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.112094615719446
FCF margin (%): 23.683716350480168
Revenue growth (%): 15.128714932340523
Rule of 40 score: 38.81243128282069
Financial ratios for SLSN — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 454000
Buffett classification: The Gruesome
Stock price: 4.4
Shares outstanding: 70632445
Market cap (USD): 310782758
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLSN — annual report dated 2022-12-31
Total revenue: 37317000
Gross profit: 8360000
Operating income: -2258000
Net income: -2623000
Capital expenditures: 2823000
Operating cash flow: -1650000
Depreciation & amortization: 567000
Net tangible assets: 5649000
Owner earnings: -4879000
Return on net tangible assets (%): -86.36926889714994
Buffett classification: The Gruesome
Stock price: 1.13
Shares outstanding: 70632445
Book value: 5649000
P/B ratio: 14.12898970614268
Market cap (USD): 79814662.85
Debt to equity: 3.2049920339883164
Current ratio: 1.201662450307192
Quick ratio: 0.5627755692085291
Interest coverage ratio: -5.9109947643979055
COGS to revenue (%): 77.59734169413403
R&D to revenue (%): 8.138381970683604
SG&A to revenue (%): 20.31513787281936
Free cash flow (dilution-adjusted): -5098000
Buyback yield (%): 0
Retained earnings: -100070000
Inventory turnover: 3.276049326846928
Receivables turnover: 7.88276299112801
Capitalized R&D asset: 3037000
ROCI (R&D-adjusted, %): -1.0251903925014647
FCF margin (%): -13.661333976471848
Rule of 40 score: -13.661333976471848
Financial ratios for SLSN — annual report dated 2023-12-31
Total revenue: 37297000
Gross profit: 7825000
Operating income: -3546000
Net income: -4390000
Capital expenditures: 1051000
Operating cash flow: -2006000
Depreciation & amortization: 742000
Net tangible assets: 1902000
Owner earnings: -4699000
Return on net tangible assets (%): -247.05573080967406
Buffett classification: The Gruesome
Stock price: 0.6
Shares outstanding: 70632445
Book value: 1902000
P/B ratio: 22.281528391167193
Market cap (USD): 42379467
Debt to equity: 11.177181913774973
Current ratio: 1.045737378921034
Quick ratio: 0.40227083199692093
Interest coverage ratio: -4.231503579952268
COGS to revenue (%): 79.01976030243719
R&D to revenue (%): 10.287690698983832
SG&A to revenue (%): 20.20001608708475
Free cash flow (dilution-adjusted): -3830000
Buyback yield (%): 0
Retained earnings: -104663000
Inventory turnover: 2.938091915063304
Receivables turnover: 10.757715604268821
Capitalized R&D asset: 5871790
ROCI (R&D-adjusted, %): -8.635604680120712
Rosenberg metric: -0.17616068488640105
FCF margin (%): -10.268922433439688
Revenue growth (%): -0.05359487632982287
Rule of 40 score: -10.32251730976951
Financial ratios for SLSN — quarterly report dated 2024-09-30
Capital expenditures: 1403000
Buffett classification: The Gruesome
Stock price: 1.62
Shares outstanding: 70632445
Market cap (USD): 114424560.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLSN — annual report dated 2024-12-31
Total revenue: 52347000
Gross profit: 16188000
Operating income: 5132000
Net income: 4235000
Capital expenditures: 4558000
Operating cash flow: 1971000
Depreciation & amortization: 928000
Net tangible assets: 14946000
Owner earnings: 605000
Return on net tangible assets (%): 4.047905794192426
Capex to operating income (%): 88.81527669524552
Buffett classification: The Gruesome
Stock price: 2.44
P/E ratio: 40.69496240850059
Shares outstanding: 70632445
Book value: 14946000
P/B ratio: 11.531056188946875
Market cap (USD): 172343165.79999998
Debt to equity: 1.023484544359695
Current ratio: 1.138711054204012
Quick ratio: 0.35234547782563147
Effective tax rate (%): 5.087404751232631
Interest coverage ratio: 7.659701492537313
COGS to revenue (%): 69.07559172445413
R&D to revenue (%): 7.329932947446845
SG&A to revenue (%): 13.790666131774504
Free cash flow (dilution-adjusted): -3312000
Buyback yield (%): 0
Retained earnings: -100428000
Inventory turnover: 1.784131839936843
Receivables turnover: 10.751078250154036
Capitalized R&D asset: 7410000
ROCI (R&D-adjusted, %): 17.063329013769923
Rosenberg metric: 2.1795673703414127
FCF margin (%): -6.327010143847785
Revenue growth (%): 40.351770919913136
Rule of 40 score: 34.02476077606535
Financial ratios for SLSN — quarterly report dated 2024-12-31
Capital expenditures: 2593000
Buffett classification: The Gruesome
Stock price: 2.44
Shares outstanding: 70632445
Market cap (USD): 172343165.79999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLSN — quarterly report dated 2025-03-31
Total revenue: 14625000
Gross profit: 3382000
Operating income: 256000
Net income: 80000
Capital expenditures: 133000
Operating cash flow: -7221000
Depreciation & amortization: 226000
Net tangible assets: 15156000
Owner earnings: 173000
Return on net tangible assets (%): 1.1414621272103458
Capex to operating income (%): 51.953125
Buffett classification: The Good
Stock price: 2.05
P/E ratio: 452.48910078125
Shares outstanding: 70632445
Book value: 15156000
P/B ratio: 9.553741900897332
Market cap (USD): 144796512.25
Debt to equity: 1.488255476378992
Current ratio: 1.0921036622460154
Quick ratio: 0.4255992213164619
Effective tax rate (%): 0
Interest coverage ratio: 1.4545454545454546
COGS to revenue (%): 76.87521367521367
R&D to revenue (%): 6.960683760683761
SG&A to revenue (%): 14.413675213675214
Free cash flow (dilution-adjusted): -7348000
Buyback yield (%): 0
Retained earnings: -100348000
Inventory turnover: 0.5130978459291712
Receivables turnover: 1.6097963676389653
Capitalized R&D asset: 1018000
ROCI (R&D-adjusted, %): 3.7151866868060526
FCF margin (%): -50.24273504273504
Rule of 40 score: -50.24273504273504
Financial ratios for SLSN — quarterly report dated 2025-06-30
Total revenue: 20359000
Gross profit: 5877000
Operating income: 1910000
Net income: 2667000
Capital expenditures: 1408000
Operating cash flow: -654000
Depreciation & amortization: 225000
Net tangible assets: 18188000
Owner earnings: 1484000
Return on net tangible assets (%): 8.15922586320651
Capex to operating income (%): 73.71727748691099
Buffett classification: The Good
Stock price: 4.36
P/E ratio: 112.1068293410994
Shares outstanding: 70632445
Book value: 18188000
P/B ratio: 16.9319034638223
Market cap (USD): 307957460.20000005
Debt to equity: 1.446668132834836
Current ratio: 1.7203585374511892
Quick ratio: 0.8403443379481718
Effective tax rate (%): 12.757605495583906
Interest coverage ratio: 21.95402298850575
COGS to revenue (%): 71.13315978191463
R&D to revenue (%): 4.690800137531313
SG&A to revenue (%): 14.79443980549143
Free cash flow (dilution-adjusted): -2049000
Buyback yield (%): 0
Retained earnings: -97681000
Inventory turnover: 0.7302339653085922
Receivables turnover: 1.8426101909675083
Capitalized R&D asset: 1637060
ROCI (R&D-adjusted, %): 5.651560392239799
Rosenberg metric: 2.450884086444008
FCF margin (%): -10.064345007122158
Revenue growth (%): 39.20683760683761
Rule of 40 score: 29.142492599715453
Financial ratios for SLSN — quarterly report dated 2025-09-30
Total revenue: 14597000
Gross profit: 3370000
Operating income: -781000
Net income: -1120000
Capital expenditures: 418000
Operating cash flow: -2511000
Depreciation & amortization: 225000
Net tangible assets: 17227000
Owner earnings: -1313000
Return on net tangible assets (%): -7.621756544958496
Buffett classification: The Gruesome
Stock price: 3.22
P/E ratio: 139.7888585740627
Shares outstanding: 70632445
Book value: 17227000
P/B ratio: 13.2023261682243
Market cap (USD): 227436472.9
Debt to equity: 1.4618912172752074
Current ratio: 1.8356471115091806
Quick ratio: 0.7793887147335423
Interest coverage ratio: -2.303834808259587
COGS to revenue (%): 76.91306432828662
R&D to revenue (%): 7.4124820168527785
SG&A to revenue (%): 21.024868123587037
Free cash flow (dilution-adjusted): -3051000
Buyback yield (%): 0
Retained earnings: -98801000
Inventory turnover: 0.5949970851661456
Receivables turnover: 1.5034504068390153
Capitalized R&D asset: 2057790
ROCI (R&D-adjusted, %): -1.8787807516118273
Rosenberg metric: -2.6251308900523562
FCF margin (%): -20.901555114064536
Revenue growth (%): -28.301979468539713
Rule of 40 score: -49.20353458260425
Financial ratios for SLSN — quarterly report dated 2025-12-31
Total revenue: 12483000
Gross profit: 3434000
Operating income: 186000
Net income: 163000
Capital expenditures: 450000
Operating cash flow: 1819000
Depreciation & amortization: 221000
Net tangible assets: 17634000
Owner earnings: -66000
Return on net tangible assets (%): -0.374276964954066
Capex to operating income (%): 241.93548387096774
Buffett classification: The Gruesome
Stock price: 1.6
P/E ratio: 63.135146368715084
Shares outstanding: 70632445
Book value: 17634000
P/B ratio: 6.408750822275151
Market cap (USD): 113011912
Debt to equity: 1.3791539072246797
Current ratio: 2.065905664441094
Quick ratio: 0.7369516835379424
Interest coverage ratio: 0.5670731707317073
COGS to revenue (%): 72.49058719859008
R&D to revenue (%): 8.29127613554434
SG&A to revenue (%): 17.72811022991268
Free cash flow (dilution-adjusted): 1163000
Buyback yield (%): 0
Retained earnings: -98638000
Inventory turnover: 0.4888444708551672
Receivables turnover: 1.8260678759508484
Capitalized R&D asset: 2075090
ROCI (R&D-adjusted, %): 0.5156920915083837
Rosenberg metric: 0.059149722735674676
FCF margin (%): 9.316670672114075
Revenue growth (%): -14.482427896143044
Rule of 40 score: -5.165757224028969
Financial ratios for SLSN — annual report dated 2025-12-31
Total revenue: 62064000
Gross profit: 16063000
Operating income: 1572000
Net income: 1790000
Capital expenditures: 2143000
Operating cash flow: -8567000
Depreciation & amortization: 897000
Net tangible assets: 17634000
Owner earnings: 544000
Return on net tangible assets (%): 3.084949529318362
Capex to operating income (%): 136.323155216285
Buffett classification: The Gruesome
Stock price: 1.6
P/E ratio: 63.135146368715084
Shares outstanding: 70632445
Book value: 17634000
P/B ratio: 6.408750822275151
Market cap (USD): 113011912
Debt to equity: 1.3791539072246797
Current ratio: 2.065905664441094
Quick ratio: 0.7369516835379424
Effective tax rate (%): 3.9184111647879765
Interest coverage ratio: 1.6885069817400644
COGS to revenue (%): 74.11865171435937
R&D to revenue (%): 6.5899716421758185
SG&A to revenue (%): 16.758507347254447
Free cash flow (dilution-adjusted): -11285000
Buyback yield (%): 0
Retained earnings: -98638000
Inventory turnover: 2.485062935551834
Receivables turnover: 9.078993563487419
Capitalized R&D asset: 7927000
ROCI (R&D-adjusted, %): 3.951301084299972
Rosenberg metric: -0.032577534532186606
FCF margin (%): -18.1828435163702
Revenue growth (%): 18.56266834775632
Rule of 40 score: 0.3798248313861201
Financial ratios for SRJ.AX — annual report dated 2021-12-31
Capital expenditures: 332951.35135135136
Net tangible assets: 523644.5945945946
Buffett classification: The Gruesome
Stock price: 0.3115942028985507
Shares outstanding: 1741000000
Book value: 2534771.621621622
P/B ratio: 214.01750856722995
Market cap (USD): 542485507.2463768
Debt to equity: 0
Current ratio: 1.534153938587268
Quick ratio: 1.5072750416351
Buyback yield (%): 0
Retained earnings: -17905332.43243243
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SRJ.AX — annual report dated 2022-12-31
Total revenue: 1040350.6024096386
Gross profit: 568700
Operating income: -4269498.795180723
Net income: -3885939.7590361447
Capital expenditures: 47739.759036144584
Depreciation & amortization: 261785.5421686747
Net tangible assets: -189728.9156626506
Owner earnings: -3671893.975903615
Buffett classification: The Gruesome
Stock price: 0.06756756756756757
Shares outstanding: 1741000000
Book value: 729371.0843373495
P/B ratio: 161.2829705773288
Market cap (USD): 117635135.13513514
Debt to equity: 0.6960114176597101
Current ratio: 0.7730208435664883
Quick ratio: 0.7519280278704455
Interest coverage ratio: -1293.3153284671532
COGS to revenue (%): 45.335735983351306
SG&A to revenue (%): 439.89144067511995
Free cash flow (dilution-adjusted): -3094015.6626506024
Buyback yield (%): 0
Retained earnings: -19849730.120481927
Inventory turnover: 15.068129330254042
Receivables turnover: 3.133188192819173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -549.9276060652617
FCF margin (%): -297.4012467993297
Rule of 40 score: -297.4012467993297
Financial ratios for SRJ.AX — annual report dated 2023-12-31
Total revenue: 1950013.9240506329
Gross profit: 1631044.3037974683
Operating income: -1754630.3797468354
Net income: -1176869.6202531646
Capital expenditures: 24031.645569620254
Depreciation & amortization: 171713.9240506329
Net tangible assets: 134963.2911392405
Owner earnings: -1029187.341772152
Return on net tangible assets (%): -762.5683495746619
Buffett classification: The Gruesome
Stock price: 0.05479452054794521
Shares outstanding: 1741000000
Book value: 982559.4936708861
P/B ratio: 97.09056895635315
Market cap (USD): 95397260.27397262
Debt to equity: 0.0644145618135018
Current ratio: 1.1153048758791646
Quick ratio: 1.0151186649745592
Interest coverage ratio: -9.76126360857992
COGS to revenue (%): 16.35729962330681
SG&A to revenue (%): 164.81732360236313
Free cash flow (dilution-adjusted): -960841.7721518987
Buyback yield (%): 0
Retained earnings: -22031649.36708861
Inventory turnover: 2.9831419438854034
Receivables turnover: 2.2993834024660917
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -172.2149335321158
FCF margin (%): -49.2735851934845
Revenue growth (%): 87.4381501326621
Rule of 40 score: 38.1645649391776
Financial ratios for SRJ.AX — annual report dated 2024-12-31
Total revenue: 2587161.25
Gross profit: 1866487.5
Operating income: -2544662.5
Net income: -1856387.5
Capital expenditures: 32310
Depreciation & amortization: 645816.25
Net tangible assets: 876981.25
Owner earnings: -1242881.25
Return on net tangible assets (%): -141.72267080966668
Buffett classification: The Gruesome
Stock price: 0.031055900621118012
Shares outstanding: 1741000000
Book value: 13666247.5
P/B ratio: 3.956340098579838
Market cap (USD): 54068322.981366456
Debt to equity: 0.0028128606627386196
Current ratio: 1.632674507061553
Quick ratio: 1.5530426811693496
Interest coverage ratio: -85.09153987627487
COGS to revenue (%): 27.85577242237994
SG&A to revenue (%): 145.53919861005957
Free cash flow (dilution-adjusted): -1979398.75
Buyback yield (%): 1.9437282165422172
Retained earnings: -24062908.75
Inventory turnover: 6.841893527638668
Receivables turnover: 2.6499450736576335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.31323363291796
FCF margin (%): -76.50851874810664
Revenue growth (%): 32.67398853367487
Rule of 40 score: -43.834530214431766
Financial ratios for SRJ.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 876981.25
Buffett classification: The Gruesome
Stock price: 0.031055900621118012
Shares outstanding: 1741000000
Book value: 13666247.5
P/B ratio: 3.956340098579838
Market cap (USD): 54068322.981366456
Debt to equity: 0.0028128606627386196
Current ratio: 1.632674507061553
Quick ratio: 1.5530426811693496
Buyback yield (%): 0
Retained earnings: -24062908.75
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STX.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.24060150375939848
Shares outstanding: 3599396998
Market cap (USD): 866020330.3458647
Buyback yield (%): 0.21566112335797422
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STX.AX — annual report dated 2022-06-30
Operating income: -10816551.724137932
Net income: -10850344.827586208
Capital expenditures: 269655.1724137931
Depreciation & amortization: 386206.8965517242
Net tangible assets: 79480000
Owner earnings: -10733793.103448275
Return on net tangible assets (%): -13.505024035541362
Buffett classification: The Gruesome
Stock price: 0.1724137931034483
Shares outstanding: 3599396998
Book value: 80602758.62068966
P/B ratio: 7.699310791963995
Market cap (USD): 620585689.3103448
Debt to equity: 0.15794787548984376
Current ratio: 1.5543983633996652
Quick ratio: 1.5543983633996652
Interest coverage ratio: -3.849779086892489
Free cash flow (dilution-adjusted): -43122758.62068965
Buyback yield (%): 0
Retained earnings: -129862758.62068966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.597870155143523
Rule of 40 score: 0
Financial ratios for STX.AX — annual report dated 2023-06-30
Operating income: -14130463.57615894
Net income: -12161589.40397351
Capital expenditures: 20727814.569536425
Depreciation & amortization: 411258.27814569534
Net tangible assets: 189106622.5165563
Owner earnings: -32478145.69536424
Return on net tangible assets (%): -17.174515235457065
Buffett classification: The Gruesome
Stock price: 0.2913907284768212
Shares outstanding: 3599396998
Book value: 189964238.410596
P/B ratio: 5.521201896209115
Market cap (USD): 1048830913.3245033
Debt to equity: 0.10711671070888212
Current ratio: 5.736710635873615
Quick ratio: 5.736710635873615
Interest coverage ratio: -3.0014066676044453
Free cash flow (dilution-adjusted): -52757615.894039735
Buyback yield (%): 0.07577026731944636
Retained earnings: -131021192.05298012
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.687561705662033
Rule of 40 score: 0
Financial ratios for STX.AX — annual report dated 2024-06-30
Total revenue: 30397333.333333332
Gross profit: 13703333.333333334
Operating income: -900666.6666666666
Net income: 5722666.666666667
Capital expenditures: 16473333.333333334
Depreciation & amortization: 2591333.3333333335
Net tangible assets: 300986000
Owner earnings: -8159333.333333334
Return on net tangible assets (%): -2.7108680580935105
Buffett classification: The Gruesome
Stock price: 0.18666666666666668
P/E ratio: 117.40810338303821
Shares outstanding: 3599396998
Book value: 301626666.6666667
P/B ratio: 2.2275465463707893
Market cap (USD): 671887439.6266667
Debt to equity: 0.052829104411634686
Current ratio: 1.3916125744921244
Quick ratio: 1.283258379671681
Interest coverage ratio: -0.0851023622047244
COGS to revenue (%): 54.91929116589175
SG&A to revenue (%): 25.978155978594614
Free cash flow (dilution-adjusted): -51414666.666666664
Buyback yield (%): 0.03462881621897078
Retained earnings: -126172666.66666667
Inventory turnover: 5.1198118994070745
Receivables turnover: 2.8712846347607055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.28026196506994105
FCF margin (%): -169.14203000263183
Rule of 40 score: -169.14203000263183
Financial ratios for SUMEETINDS.NS — annual report dated 2022-03-31
Total revenue: 117829935.38177502
Gross profit: 11248450.48133984
Operating income: 1948239.4830542002
Net income: 384254.2529341949
Capital expenditures: 155149.67690887512
Operating cash flow: 7981498.087828036
Depreciation & amortization: 4142146.9075563764
Net tangible assets: -6965844.652512198
Owner earnings: 4371251.483581697
Return on net tangible assets (%): -62.752640945060776
Capex to operating income (%): 7.963583443327579
Buffett classification: The Great
Stock price: 0.3782144270077806
P/E ratio: 601.4798154011944
Shares outstanding: 611085037
Book value: -6965844.652512208
Market cap (USD): 231121177.12198338
Debt to equity: -9.869024270190438
Current ratio: 0.6418829063336329
Quick ratio: 0.3653290614702917
Interest coverage ratio: 0.6039095617481022
COGS to revenue (%): 90.45365641176473
SG&A to revenue (%): 1.3638992712291065
Free cash flow (dilution-adjusted): 7820809.70592114
Buyback yield (%): 0
Retained earnings: -31247421.86469735
Inventory turnover: 5.193667664863058
Receivables turnover: 7.667860964815547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 43.39837140439942
FCF margin (%): 6.637370784072244
Rule of 40 score: 6.637370784072244
Financial ratios for SUMEETINDS.NS — annual report dated 2023-03-31
Total revenue: 125837295.98051158
Gross profit: -114799.02557856274
Operating income: -8088684.531059684
Net income: -7152460.414129111
Capital expenditures: 101863.58099878198
Operating cash flow: 8887064.55542022
Depreciation & amortization: 3348647.9902557856
Net tangible assets: -14171230.207064556
Owner earnings: -3905676.0048721074
Buffett classification: The Gruesome
Stock price: 0.10316686967113278
Shares outstanding: 611085037
Book value: -14170109.62241169
Market cap (USD): 63043730.37015835
Debt to equity: -3.946578290924783
Current ratio: 0.5168289311004621
Quick ratio: 0.3078073641236625
Interest coverage ratio: -11.52118320610687
COGS to revenue (%): 100.09122814081792
SG&A to revenue (%): 1.084293640590357
Free cash flow (dilution-adjusted): 8783495.736906212
Buyback yield (%): 0
Retained earnings: -36013507.91717418
Inventory turnover: 10.040242853342292
Receivables turnover: 9.85972058257931
Capitalized R&D asset: 0
FCF margin (%): 6.980041702633623
Revenue growth (%): 6.795692938973696
Rule of 40 score: 13.775734641607318
Financial ratios for SUMEETINDS.NS — annual report dated 2024-03-31
Total revenue: 118102518.28756446
Gross profit: 106331.69444777552
Operating income: -7578366.710636767
Net income: -7076579.9256505575
Capital expenditures: 1187.1927089579085
Operating cash flow: 1773701.8827197505
Depreciation & amortization: 2867130.3513610745
Net tangible assets: -21189123.396090657
Owner earnings: -4210636.766998441
Buffett classification: The Gruesome
Stock price: 0.11552303262955856
Shares outstanding: 611085037
Book value: -21188523.803813405
Market cap (USD): 70594396.668786
Debt to equity: -2.6039500574731838
Current ratio: 0.4739584050120458
Quick ratio: 0.28067633660807256
Interest coverage ratio: -70217.77777777778
COGS to revenue (%): 99.9099666154545
SG&A to revenue (%): 0.9875140236109428
Free cash flow (dilution-adjusted): 1772514.6900107926
Buyback yield (%): 0
Retained earnings: -42532965.58340328
Inventory turnover: 9.597518225107635
Receivables turnover: 12.007433498413814
Capitalized R&D asset: 0
FCF margin (%): 1.5008271760090222
Revenue growth (%): -6.146649634099739
Rule of 40 score: -4.645822458090716
Financial ratios for SUMEETINDS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -18197897.754419494
Buffett classification: The Gruesome
Stock price: 0.19493549928332538
Shares outstanding: 611085037
Book value: -18197897.7544195
Market cap (USD): 119122166.79216436
Debt to equity: -3.0283178254682546
Current ratio: 0.530087147458438
Quick ratio: 0.2892166869856415
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUMEETINDS.NS — quarterly report dated 2024-12-31
Total revenue: 29346310.758829698
Gross profit: 6468656.020515211
Operating income: 133477.09523254458
Net income: 11327928.663014337
Capital expenditures: 0
Depreciation & amortization: 610770.4860706376
Owner earnings: 11938699.149084974
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.21948945098496325
P/E ratio: 2.960089246372539
Shares outstanding: 611085037
Market cap (USD): 134126719.27625595
Effective tax rate (%): 0
Interest coverage ratio: 0.5897105778143991
COGS to revenue (%): 77.95751543124062
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUMEETINDS.NS — annual report dated 2025-03-31
Total revenue: 117298398.41010053
Gross profit: 24019043.72223521
Operating income: -990156.6518587795
Net income: 19904255.319148935
Capital expenditures: 261491.6997895721
Operating cash flow: 22864250.642974045
Depreciation & amortization: 2430021.042787
Net tangible assets: 21651309.3289689
Owner earnings: 22072784.662146363
Return on net tangible assets (%): 101.94665055481676
Buffett classification: The Gruesome
Stock price: 0.21974559458513243
P/E ratio: 6.746459118641588
Shares outstanding: 611085037
Book value: 21651636.66121113
P/B ratio: 6.201990496090804
Market cap (USD): 134283244.79764265
Debt to equity: 0.38427207017403664
Current ratio: 1.6174525323330053
Quick ratio: 0.9894432313305945
Effective tax rate (%): 5.1962464036758655
Interest coverage ratio: -2.360985672074483
COGS to revenue (%): 79.52312729943725
SG&A to revenue (%): 1.0456954833732903
Free cash flow (dilution-adjusted): 22479027.3556231
Buyback yield (%): 0
Retained earnings: -14248491.933598315
Inventory turnover: 7.561623635819153
Receivables turnover: 11.955960401419409
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.2519657195556793
FCF margin (%): 19.163967846373797
Revenue growth (%): -0.6808659875532825
Rule of 40 score: 18.483101858820515
Financial ratios for SUMEETINDS.NS — quarterly report dated 2025-03-31
Total revenue: 28410591.536123447
Gross profit: 6197276.128127191
Operating income: 119172.31704465747
Net income: 7911959.317278465
Capital expenditures: 0
Depreciation & amortization: 598468.5527238718
Net tangible assets: 21651309.3289689
Owner earnings: 8510427.870002337
Return on net tangible assets (%): 39.30675849989174
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.21974559458513243
P/E ratio: 4.243046488636176
Shares outstanding: 611085037
Book value: 21651636.66121113
P/B ratio: 6.201990496090804
Market cap (USD): 134283244.79764265
Debt to equity: 0.38427207017403664
Current ratio: 1.6174525323330053
Quick ratio: 0.9894432313305945
Effective tax rate (%): 12.117879264001246
Interest coverage ratio: 0.625398773006135
COGS to revenue (%): 78.18674025055941
Buyback yield (%): 0
Retained earnings: -14248491.933598315
Inventory turnover: 1.8007063983351212
Receivables turnover: 2.895827325785072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.39139694615162807
Revenue growth (%): -3.188541245937404
Rule of 40 score: -3.188541245937404
Financial ratios for SUMEETINDS.NS — quarterly report dated 2025-06-30
Total revenue: 29074959.04516733
Gross profit: 7224046.337467821
Operating income: 998350.1053124269
Net income: 933746.7821202902
Capital expenditures: 0
Depreciation & amortization: 593014.2756845308
Owner earnings: 1526761.057804821
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.18417973320851863
P/E ratio: 5.579038205454007
Shares outstanding: 611085037
Market cap (USD): 112549479.08237773
Effective tax rate (%): 0
Interest coverage ratio: 4.4735213926174495
COGS to revenue (%): 75.15371792529297
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.3384501100554513
Rule of 40 score: 2.3384501100554513
Financial ratios for SUMEETINDS.NS — quarterly report dated 2025-09-30
Total revenue: 30360631.341600902
Gross profit: 6947080.045095828
Operating income: 1162356.2570462232
Net income: 1111352.8748590755
Capital expenditures: 0
Depreciation & amortization: 473878.2412626832
Net tangible assets: 22883269.4475761
Owner earnings: 1585231.1161217587
Return on net tangible assets (%): 6.927467771829579
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.3904171364148816
P/E ratio: 11.208748359042858
Shares outstanding: 611085037
Book value: 22883269.447576094
P/B ratio: 10.42587340056835
Market cap (USD): 238578070.25152197
Debt to equity: 0.4826446264705043
Current ratio: 1.7976344121637848
Quick ratio: 1.1790338436277472
Effective tax rate (%): 0
Interest coverage ratio: 4.783159359777314
COGS to revenue (%): 77.11813049296914
Buyback yield (%): 0
Inventory turnover: 1.9857511937749677
Receivables turnover: 2.656162956767377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.41698853215418
Revenue growth (%): 4.42192298340406
Rule of 40 score: 4.42192298340406
Financial ratios for SUMEETINDS.NS — quarterly report dated 2025-12-31
Total revenue: 29734298.76350674
Gross profit: 6942207.864542721
Operating income: 1210426.6458727862
Net income: 1006761.7244068175
Capital expenditures: 0
Depreciation & amortization: 554840.1470424418
Owner earnings: 1561601.871449259
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.3415394898072853
P/E ratio: 19.036217163900368
Shares outstanding: 611085037
Market cap (USD): 208709671.76584607
Effective tax rate (%): 0
Interest coverage ratio: 4.313102846028659
COGS to revenue (%): 76.65252535545592
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.062976131975047
Rule of 40 score: -2.062976131975047
Financial ratios for TGN.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09774436090225563
Shares outstanding: 1396340206
Market cap (USD): 136484381.037594
Buyback yield (%): 0.002623341294146566
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TGN.AX — annual report dated 2022-06-30
Operating income: -3800046.896551724
Net income: -3506999.310344828
Capital expenditures: 93253.10344827587
Depreciation & amortization: 198986.89655172414
Net tangible assets: 24429713.79310345
Owner earnings: -3401265.5172413797
Return on net tangible assets (%): -13.922658063237575
Buffett classification: The Gruesome
Stock price: 0.06896551724137931
Shares outstanding: 1396340206
Book value: 24429713.79310345
P/B ratio: 3.9418932766584276
Market cap (USD): 96299324.55172414
Debt to equity: 0.011635096152692518
Current ratio: 16.514199613662324
Quick ratio: 16.514199613662324
Free cash flow (dilution-adjusted): -3449642.7586206896
Buyback yield (%): 0
Retained earnings: -37854317.24137931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.272630835354922
Rule of 40 score: 0
Financial ratios for TGN.AX — annual report dated 2023-06-30
Operating income: -2977987.417218543
Net income: -1943451.6556291392
Capital expenditures: 10243.708609271524
Depreciation & amortization: 287033.11258278147
Net tangible assets: 21515545.03311258
Owner earnings: -1666662.2516556291
Return on net tangible assets (%): -7.746316670531114
Buffett classification: The Gruesome
Stock price: 0.059602649006622516
Shares outstanding: 1396340206
Book value: 21515545.03311258
P/B ratio: 3.8681602099304575
Market cap (USD): 83225575.19205298
Debt to equity: 0.025309345871688094
Current ratio: 8.943127377101996
Quick ratio: 8.943127377101996
Free cash flow (dilution-adjusted): -1276962.9139072848
Buyback yield (%): 0
Retained earnings: -38293623.8410596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.371355755070368
Rule of 40 score: 0
Financial ratios for TGN.AX — annual report dated 2024-06-30
Operating income: -4260025.333333333
Net income: -3408650
Capital expenditures: 28318
Depreciation & amortization: 661863.3333333334
Net tangible assets: 18250332
Owner earnings: -2775104.6666666665
Return on net tangible assets (%): -15.20577634788598
Buffett classification: The Gruesome
Stock price: 0.04
Shares outstanding: 1396340206
Book value: 18250332
P/B ratio: 3.0604160099662847
Market cap (USD): 55853608.24
Debt to equity: 0.023419153872561514
Current ratio: 6.503696220149435
Quick ratio: 6.503696220149435
Free cash flow (dilution-adjusted): -2708630.6666666665
Buyback yield (%): 0
Retained earnings: -41957564.666666664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.387941835141635
Rule of 40 score: 0
Financial ratios for TM5.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 113.05681818181817
Shares outstanding: 1072671613
Market cap (USD): 121272839519.73863
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0